Precision Biosciences, Inc. · NASDAQ:DTIL
Tang Capital Management LLC reported a 6.40% stake in Precision Biosciences, Inc. (Schedule 13G/A)
Event Mar 31, 2025 · Filed May 15, 2025
Tang Capital Management LLC reported a 6.40% stake in Precision Biosciences, Inc., 673,332 shares, as a passive investor on Mar 31, 2025. Filed May 15, 2025 (Schedule 13G/A).
- Stake
- 6.40%
- Shares
- 673,332
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 6 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| TANG CAPITAL MANAGEMENT, LLC | 6.40% | 673,332 |
| KEVIN TANG | 6.40% | 673,332 |
| TANG CAPITAL PARTNERS, LP | 3.60% | 378,682 |
| TANG CAPITAL PARTNERS INTERNATIONAL, LP | 2.80% | 294,650 |
| TANG CAPITAL PARTNERS III, INC | 0% | 0 |
| TANG CAPITAL PARTNERS IV, INC | 0% | 0 |
Source
Related
- Precision Biosciences, Inc.
- Tang Capital Management LLC
- Precision Biosciences, Inc. shareholders
- Schedule 13G/A · Tang Capital Management LLC · Feb 17, 2026
- Form 4 · Frankel Stanley · Sep 30, 2026
- Form 4 · Brown Melinda · Sep 29, 2026
- Form 4 · Germano Geno J · Sep 29, 2026
- Schedule 13G/A · Weinstein Benjamin · Aug 24, 2026
- Schedule 13G/A · Empery Asset Management, LP · Jul 29, 2026